Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Trends in Parasitology|October 21, 2020
Immunotherapeutic Potential of Interleukin-32 and Trained Immunity for Leishmaniasis TreatmentLisa U Teufel, Leo A B Joosten, Jéssica Cristina Dos SantosImmunology Letters|June 20, 2024
Differential structure and immunomodulatory functions of lipophosphoglycan between Leishmania sppLisa U Teufel, Leo A B Joosten, Jéssica C Dos SantosCytokine|November 29, 2021
IL-1 family cytokines as drivers and inhibitors of trained immunityLisa U Teufel, Rob J W Arts, Mihai G Netea, et al.Frontiers in Immunology|August 26, 2022
Circulating interleukin-38 concentrations in healthy adultsLisa U Teufel, Dennis M de Graaf, Mihai G Netea, et al.International Journal of Molecular Sciences|February 11, 2023
Opposing Effects of Interleukin-36γ and Interleukin-38 on Trained ImmunityLisa U Teufel, Mihai G Netea, Frank L van de Veerdonk, et al.Biomacromolecules|September 23, 2021
Bimodal Targeting of Human Leukocytes by Fc- and CpG-Decorated Polymersomes to Tune Immune InductionLucille F van Beek, Pascal L W Welzen, Lisa U Teufel, et al.Cytokine|December 8, 2022
Effect of exogenous IL-37 on immune cells from a patient carrying a potential IL37 loss-of-function variant: A case studyLisa U Teufel, Caspar I van der Made, Viola Klück, et al.Journal of Leukocyte Biology|February 23, 2021
IL-38 prevents induction of trained immunity by inhibition of mTOR signalingDennis M de Graaf, Lisa U Teufel, Frank L van de Veerdonk, et al.Clinical Immunology (Orlando, Fla.)|September 22, 2024
Insights into the multifaceted role of interleukin-37 on human immune cell regulationLisa U Teufel, Vasiliki Matzaraki, Lukas Folkman, et al.Vaccine|October 1, 2024
Interleukin 38 reduces antigen-presentation capacity and antibody production after vaccinationLisa U Teufel, Esther J M Taks, Jelle van Gemert, et al.Pageof 2